Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022119429 - FIXED COMBINATION MEDICINE FOR THE CONTROL AND MANAGEMENT OF NEUROPATHIC PAIN

Publication Number WO/2022/119429
Publication Date 09.06.2022
International Application No. PCT/MX2020/050049
International Filing Date 04.12.2020
IPC
A61K 31/192 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/51 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
51Thiamines, e.g. vitamin B1
A61K 31/4415 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4415Pyridoxine, i.e.vitamin B6
A61K 31/714 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7135Compounds containing heavy metals
714Cobalamins, e.g. cyanocobalamin, vitamin B12
A61P 29/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC
A61K 31/192
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
A61K 31/4415
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
4415Pyridoxine, i.e. Vitamin B6
A61K 31/51
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
51Thiamines, e.g. vitamin B1
A61K 31/714
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7135Compounds containing heavy metals
714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
Applicants
  • LABORATORIOS SILANES S.A. DE C.V. [MX]/[MX]
Inventors
  • MUÑOZ MARTÍNEZ, Cecilia Jannette
  • GONZÁLEZ CANUDAS, Jorge Alejandro
  • OLLERVIDES RUBIO, Paola Yazmín
  • ESPINOZA LEÓN, Sixto Serafín
  • FARFÁN SALAZAR, Claudia Delfina
Agents
  • FUENTES CARRASCO, Ariel
Priority Data
Publication Language Spanish (es)
Filing Language Spanish (ES)
Designated States
Title
(EN) FIXED COMBINATION MEDICINE FOR THE CONTROL AND MANAGEMENT OF NEUROPATHIC PAIN
(ES) MEDICAMENTO DE COMBINACIÓN FIJA PARA EL CONTROL Y MANEJO DEL DOLOR NEUROPÁTICO
(FR) MÉDICAMENT DE COMBINAISON FIXE POUR LA LUTTE ET LA PRISE EN CHARGE DE LA DOULEUR NEUROPATHIQUE
Abstract
(EN) The present invention relates to the manufacture of combination anti-inflammatory, antineuritic and neuropathic pain control and management drugs, in particular, acute pain of moderate to severe intensity of diverse etiology, selected from: peripheral neuropathies, lumbalgias, sciatica, cervicalgias, radiculitis, post-herpetic neuralgia, spondylitis, carpal tunnel syndrome, fibromyalgia, etc., of various etiologies such as inflammatory, medicinal, diabetic, alcoholic, nutritional, etc., and comprising a therapeutically effective amount of (a) a non-steroidal anti-inflammatory agent (NSAID) or a pharmaceutically acceptable salt thereof; (b) an antineuritic agent or a pharmaceutically acceptable salt thereof; (c) at least one pharmaceutically acceptable amount of a pharmaceutically acceptable excipient.
(ES) La presente invención se relaciona la fabricación de medicamentos de combinación antiinflamatorios, antineuríticos y para el control y manejo del dolor neuropático, en particular, dolor agudo de intensidad moderada a severa de diversa etiología, seleccionado de: neuropatías periféricas, lumbalgias, ciática, cervicalgias, radiculitis, neuralgia post-herpética, espondilitis, síndrome del túnel del carpo, fibromialgia, etc., de diversas etiologías como son inflamatorias, medicamentosas, diabéticas, alcohólicas, nutricionales, etc., y que comprende una cantidad terapéuticamente efectiva de (a) un agente antiinflamatorio no esteroideo (AINE) o una sal farmacéuticamente aceptable del mismo; (b) un agente antineurítico o una sal farmacéuticamente aceptable del mismo; y (c) al menos una cantidad farmacéuticamente aceptable de un excipiente farmacéuticamente aceptable.
(FR) La présente invention concerne la fabrication de médicaments de combinaison anti-inflammatoires, anti-neuritiques et pour la lutte et la prise en charge de la douleur neuropathique, notamment, la douleur aiguë d'intensité modérée à sévère d'origines diverses, sélectionnées parmi : les neuropathies périphériques, les lombalgies, les sciatiques, les cervicalgies, la radiculite, la neuralgie post-herpétique, la spondylarthrite, le syndrome du tunnel carpien, la fibromyalgie, etc., d'origines diverses notamment inflammatoires, médicamenteuses, diabétiques, alcooliques, nutritionnelles, etc. et qui comprend une quantité thérapeutiquement efficace de (a) un agent anti-inflammatoire non stéroïdien (AINE) ou un sel pharmaceutiquement acceptable de celui-ci ; (b) un agent antineuritique ou un sel pharmaceutiquement acceptable de celui-ci ; et (c) au moins une quantité thérapeutiquement acceptable d'un excipient pharmaceutiquement acceptable.
Related patent documents
MXMX/a/2022/015334This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau